Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 12
- +1 vs. Q2 2025
- Portfolio value
- $22.9M
- +$13.0M (+132.0%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RZLTRezolute, Inc. | COM NEW | 1,986,818 | $18.7M | 81.7% | +382,832+23.9% | Added | History |
| GLDSPDR Gold Trust | ETF | 7,286 | $2.59M | 11.3% | +2,334+47.1% | Added | History |
| BRK.BBerkshire Hathaway Inc | Stock | 651 | $327.5K | 1.4% | +19+3.0% | Added | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 27,011 | $318.5K | 1.4% | −7,062−20.7% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 13,097 | $268.1K | 1.2% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 53,503 | $187.3K | 0.8% | +10,038+23.1% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 10,941 | $172.8K | 0.8% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 22,981 | $137.9K | 0.6% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 17,332 | $115.1K | 0.5% | 00.0% | Unchanged | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 16,393 | $26.6K | 0.1% | 00.0% | Unchanged | History |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 10,935 | $22.0K | 0.1% | +10,935 | New | History |
| CNTXContext Therapeutics Inc. | COM | 18,403 | $17.8K | 0.1% | 00.0% | Unchanged | History |